Tenet Healthcare Corporation (THC)
NYSE: THC · Real-Time Price · USD
167.58
+0.12 (0.07%)
At close: Jun 18, 2025, 4:00 PM
167.58
0.00 (0.00%)
After-hours: Jun 18, 2025, 6:30 PM EDT
Tenet Healthcare Analyst Ratings
Total Analysts
16
Consensus Rating
Buy
Price Target
$184.50
Upside
+10.10%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $175 → $210 | Buy | Maintains | $175 → $210 | +25.31% | Jun 9, 2025 |
| Barclays | Barclays | Buy Maintains $171 → $215 | Buy | Maintains | $171 → $215 | +28.30% | Jun 2, 2025 |
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $150 → $195 | Hold → Buy | Upgrades | $150 → $195 | +16.36% | May 29, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $165 → $180 | Strong Buy | Maintains | $165 → $180 | +7.41% | May 14, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $175 → $190 | Strong Buy | Maintains | $175 → $190 | +13.38% | May 12, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $134 → $154 | Hold | Maintains | $134 → $154 | -8.10% | May 5, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $165 → $175 | Buy | Maintains | $165 → $175 | +4.43% | May 5, 2025 |
| Barclays | Barclays | Buy Maintains $161 → $171 | Buy | Maintains | $161 → $171 | +2.04% | Apr 30, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $183 → $189 | Buy | Maintains | $183 → $189 | +12.78% | Apr 30, 2025 |
| UBS | UBS | Strong Buy Maintains $217 → $230 | Strong Buy | Maintains | $217 → $230 | +37.25% | Apr 30, 2025 |
| Baird | Baird | Buy → Hold Downgrades $153 → $137 | Buy → Hold | Downgrades | $153 → $137 | -18.25% | Apr 15, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $165 | Strong Buy | Initiates | $165 | -1.54% | Apr 9, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $165 | Buy | Initiates | $165 | -1.54% | Mar 26, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $177 | Buy | Reiterates | $177 | +5.62% | Feb 13, 2025 |
| Barclays | Barclays | Buy Maintains $190 → $161 | Buy | Maintains | $190 → $161 | -3.93% | Feb 13, 2025 |
| Keybanc | Keybanc | Buy Maintains $200 → $185 | Buy | Maintains | $200 → $185 | +10.40% | Jan 7, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.